Home Stocks Sanofi India Ltd

Sanofi India Ltd

The live share price of Sanofi India Ltd (SANOFI) as on 15 Apr 9:59am is ₹8,505.3 from NSE/BSE.

SANOFI NSE

₹8,505.3 ▲0.44% (37.1)

As on Apr 15, 2024 03:29 PM IST

How do you feel today about Sanofi India Ltd?

Key Metrics

PE Ratio

32.35

PB Ratio

15.29

Dividend Yield

1.97%

Sector PB

5.95

Sector PE

51.96

Sector Div Yld

0.56%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

sec-img

Sector

Health Care

sec-img

Industry

Pharmaceuticals

sec-img

Market Cap

Smallcap, ₹19,502 Cr

Sanofi India Limited is engaged in the manufacture and sale of pharmaceutical products.

The following charts display the financial performance of the Sanofi India Ltd (SANOFI) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Sanofi India Ltd (SANOFI), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

sec-img

Sector

Health Care

sec-img

Industry

Pharmaceuticals

sec-img

Market Cap

Smallcap, ₹19,502 Cr

Financials

Income Statement

(INR) Y/Y Change
Revenue 2,934 Cr -1.32%
Operating Expense 2,047 Cr +1543.18%
Net Income 602 Cr -2.85%
Net Profit Margin 20.55% -1.53%
Earning Per Share 261 -2.85%
EBITDA 886 Cr -2.32%

Balance sheet

(INR) Y/Y Change
Cash & short-term Inv 1,016 Cr -34.41%
Total Assets 2,071 Cr -32.32%
Total Liabilities 795 Cr -4.73%
Total Equity 1,275 Cr -42.68%
Shares Outstanding 2.3 Cr -0.13%
Price to Book 13.46 +62.71%
Return on Assets 24.18% -23.46%
Return on Capital 67.88 Cr +19.95%

Cash Flows

(INR) Y/Y Change
Net Income 602 Cr -2.85%
Cash from Operations 398 Cr -28.65%
Cash from Investing 650 Cr +3.19%
Cash from Financing -1,582 Cr +86.42%
Net Change in Cash -533 Cr -256.52%
Free Cash Flow 376 Cr -29.73%
Total Promoter Holding
60.4%
Unpledged
Foreign Institutions
6.31%
Foreign Institutions
Retail & Others
10.58%
Retail & Others
Other Parties
Other Domestic Institutions
11.2%
Insurance Firms
Others
Mutual Funds
11.51%
Mutual Funds

Peers

SUNPHARMA

Sun Pharmaceutical Industries Ltd

PE Ratio

41.49

1Y Return

▲54.2%

CIPLA

Cipla Ltd

PE Ratio

30.41

1Y Return

▲54.1%

DRREDDY

Dr Reddy's Laboratories Ltd

PE Ratio

19.38

1Y Return

▲25.38%

ZYDUSLIFE

Zydus Lifesciences Ltd

PE Ratio

32.56

1Y Return

▲91.63%

Latest News

latest-news

Sanofi Looks For Accelerated Growth In India, Plans Fast-Tracking Of Product Pipeline

1 week ago on Bloomberg Quint

Change since news ▼-INF%

Sanofi Healthcare India recently tied up with companies like Cipla, Dr Reddy’s Laboratories and Emcure to expand the reach of its products in the country.


latest-news

Sanofi Gets Nod For New Polio Vaccine In India

1 week ago on Bloomberg Quint

Change since news ▼-INF%

Sanofi has received approval for IMOVAX-Polio, an alternative injectable vaccine, to replace ShanIP, the inactivated polio vaccine, in India.


latest-news

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

2 weeks ago on Moneycontrol

Change since news ▼-INF%

Sanofi did not disclose the financial terms of the deal. The agreement, which still needs to be finalized, will resolve most of the lawsuits against the French pharmaceutical company in U.S. state courts, with the exception of Delaware where the majority of the cases are pending.


FAQs on Sanofi India Ltd

How to buy Sanofi India Ltd stocks?

You can easily buy the stocks/shares of Sanofi India Ltd (SANOFI) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Sanofi India Ltd?

The stock price of Sanofi India Ltd as on 15 Apr 2024 is ₹8,505.3

What is the 52-week High and Low of Sanofi India Ltd?

The 52-week high and low of Sanofi India Ltd (SANOFI) is ₹9,380 and ₹5,400.

What is the PE and PB ratio of Sanofi India Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Sanofi India Ltd are 32.35 and 15.29 respectively.

What are the peers or stocks similar to Sanofi India Ltd?

The peers or stocks similar to Sanofi India Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Zydus Lifesciences Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Sanofi India Ltd belong to?

Sanofi India Ltd (SANOFI) belongs to the Pharmaceuticals sector.

What is the Market Cap of Sanofi India Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sanofi India Ltd (SANOFI) is ₹19,502 Cr as of 15 Apr 2024

Can't decide whether or not to buy Sanofi India Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.